Candesant Biomedical, Incorporated
Developing a product to selectively target the glands and ducts that produce sweat; it will address the $1.6B under-served hyperhidrosis/sweat control market
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location San Francisco, CA, US
- Currency USD
- Founded September 2015
- Employees 3
- Incorporation Type C-corp
- Website candesant.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.